Davide Rossi, MD
Oncology Institute of Southern Switzerland (IOSI) and Institute of Oncology Research (IOR) · Oncology Institute of Southern Switzerland - Bellinzona (Switzerland) · Oncology Institute of Southern Switzerland and Institute of Oncology Research
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Davide Rossi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06712459 · Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · recruiting · Transformed Splenic Marginal Zone Lymphoma · study chair
- Ph3NCT05735834 · Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL PatientsInternational Extranodal Lymphoma Study Group (IELSG) · active not recruiting · Splenic Marginal Zone Lymphoma · study chair
- N/ANCT05700149 · Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · recruiting · Nodal Marginal Zone Lymphoma · study chair
- Ph2NCT04646395 · Study of Acalabrutinib and Tafasitamab in MZL PatientsInternational Extranodal Lymphoma Study Group (IELSG) · active not recruiting · Marginal Zone Lymphoma · study chair
- Ph2NCT03708003 · Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLLSwiss Cancer Institute · terminated · Relapsed/Refractory Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Leukemia · study chair
- N/ANCT03436602 · Personalized Risk Stratification Model of Follicular Lymphoma PatientsOncology Institute of Southern Switzerland · active not recruiting · Follicular Lymphoma · principal investigator
- N/ANCT03436524 · A Prognostic Tool for Early Stage CLLOncology Institute of Southern Switzerland · completed · Chronic Lymphocytic Leukemia · principal investigator
- N/ANCT03280394 · Liquid Biopsy in Mature B-cell TumorsOncology Institute of Southern Switzerland · recruiting · Mature B-Cell Neoplasm · principal investigator
- N/ANCT02827617 · Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic LeukemiaOncology Institute of Southern Switzerland · completed · Chronic Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.